No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Suresh Krishnan Appointed COO North America Accident and Health of Chubb

Editor: What To Know

  •   Prior to this new position, he served as head of Europe’s Major Accounts Division, where he led the development of business strategies and oversaw the structures, processes and performance metrics that ensured clients and brokers fully benefited from Chubb’s risk and underwriting expertise, as well as its multinational network and services.
  • Prior to the merger between ACE and Chubb in 2016, he led Chubb Overseas General Insurance Division’s multinational and large accounts strategy, where he assembled and oversaw cross-functional teams in Asia Pacific, Africa, Eurasia, Europe and Latin America.
  • Krishnan will be responsible for developing and implementing a range of strategies related to profitable growth for the business, including sales and distribution, claims and product development for the company’s large account and middle-market insurance segments.

Chubb appoints Suresh Krishnan to Chief Operating Officer for its Accident and Health (A&H) business in the United States and Canada.

Suresh Krishnan will assist in overseeing the day-to-day operations of the business and report to James Walloga, Chubb’s Executive Vice President, North America Accident and Health.

In this capacity, Mr. Krishnan will be responsible for developing and implementing a range of strategies related to profitable growth for the business, including sales and distribution, claims and product development for the company’s large account and middle-market insurance segments.  He will also oversee Chubb’s Canada A&H business.  He will be based in New York.

Mr. Krishnan brings more than two decades of experience to his new role. Throughout his career, he has served in several senior leadership roles.  Prior to this new position, he served as head of Europe’s Major Accounts Division, where he led the development of business strategies and oversaw the structures, processes and performance metrics that ensured clients and brokers fully benefited from Chubb’s risk and underwriting expertise, as well as its multinational network and services.

“Suresh is a strategic leader who has been with Chubb for quite some time and has a deep understanding of our business, our culture, and our clients’ needs,” said Mr. Walloga. “That background is a good reflection of our overall leadership team and is key to our consistent approach to bringing innovative products and services to market, while providing superior support to our distribution partners. I look forward to working with Suresh in his new role and further building upon our successes.”

Mr. Krishnan joined Chubb in 1999 and has held a variety of executive-level legal positions. Prior to the merger between ACE and Chubb in 2016, he led Chubb Overseas General Insurance Division’s multinational and large accounts strategy, where he assembled and oversaw cross-functional teams in Asia Pacific, Africa, Eurasia, Europe and Latin America. This included leading and managing the Global Client Executive Practice for Chubb’s Overseas General Insurance Division.

“This is yet another example of the depth of unmatched leadership that distinguishes Chubb,” said Joe Vasquez, Chubb’s Senior Vice President, Chubb Group and head of the company’s Global Accident and Health business. “I am excited to have Suresh serve in another leadership capacity and confident he will continue to represent the world class underwriting, service, and claims support Chubb is known for.”

Succeeding Mr. Krishnan as head of the Major Accounts Division, Europe will be Chubb’s Country President for France, Nadia Côté.

Mr. Krishnan holds a Bachelor of Arts degree from Colgate University and a Juris Doctor from The University of Richmond School of Law.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy